Resotran 540 mg / ml, Injektionssuspension

7680698660019 CH-69866 Injektionssuspension

Associated product:

RESOTRAN 540 mg / ml susp inj 540 mg 1,5 ml

No image available

Article details

Package size
1,5
Selling units
1
Measure
ml
Galenic form
Injektionssuspension
Galenic group
Injektion/Infusion

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Summary of Product Characteristics
Allemand
15/08/2025
Summary of Product Characteristics
Français
15/08/2025
Summary of Product Characteristics
Italien
15/08/2025

Detailed composition

Substance Quantity Type Category
ferucarbotran
540.0 MG Substance Wirkstoff (Principe actif)
ferrum
28.0 MG Substance WIIS
acidum (S)-lacticum (90 per centum)
- Substance HNIDK
mannitolum
- Substance HNIDK
natrii hydroxidum
- Substance HNIDK
aqua ad iniectabile
- Substance HNIDK
natrium
0.72 MG Substance HBESI

Reimbursement information

Public price
CHF 321.05
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/05/2026

Authorization holder

b.e.imaging.ag

6430 Schwyz

Authorization information

Swissmedic authorization number
69866
Drug name
Resotran, Injektionssuspension
Galenic form
SUPAS
ATC Code
V08CB03
Authorization status
Z
Dispensing category
B
First authorization
16/07/2025
Authorization expiration date
15/07/2030
IT Number
14.02.0.
Domain
Human medicine
Field of application
MRT-Kontrastmittel für die Leber

Package details

Description (FR)
RESOTRAN 540 mg / ml susp inj 540 mg 1,5 ml
Description (DE)
RESOTRAN 540 mg / ml Inj Susp 540 mg 1,5 ml
Market launch
01/03/2026
Narcotic (BTM)
No
Buy us a coffee Explore the data